6 results  1 of 1 

1 Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients
Sun-Mi Cho, Kyung-Yul Lee, Jong Rak Choi, Kyung-A Lee
Yonsei Med J.2016;57(3):635-640.   Published online 2016 March 15     DOI: http://dx.doi.org/10.3349/ymj.2016.57.3.635
      
2 Evaluation of the Verigene Warfarin Metabolism Nucleic Acid Test Kit for the Rapid Detection of CYP2C9 and VKORC1 Polymorphisms
Hyeyoung Lee, Jiyeon Kim, Gun Dong Lee, Joonhong Park, Hyojin Chae, Myungshin Kim, Yonggoo Kim, Yong Seog Oh
Lab Med Online.2014;4(4):198-202.   Published online 2014 October 1     DOI: http://dx.doi.org/10.3343/lmo.2014.4.4.198
      
3 Association of CYP2C9 Genetic Variants with Vitiligo
Abdullateef A. Alzolibani, Ahmad Al Robaee, Hani Al-Shobaili, Fahad Al-Saif, Eman Al-Mekhadab, Ahmed A. Settin
Ann Dermatol.2014;26(3):343-348.   Published online 2014 June 12     DOI: http://dx.doi.org/10.5021/ad.2014.26.3.343
      
4 CYP2C9 Mutation Affecting the Individual Variability of Warfarin Dose Requirement
Young Bum Kim, Moon Ju Ko, Dae Gu Lee, Jong Gul Do, Ji Hye Hwang
Ann Rehabil Med.2012;36(6):857-860.   Published online 2012 December 28     DOI: http://dx.doi.org/10.5535/arm.2012.36.6.857
      
5 A Case Report of a Patient Carrying CYP2C9*3/4 Genotype with Extremely Low Warfarin Dose Requirement
Soo-Youn Lee, Myung-Hyun Nam, June Soo Kim, Jong-Won Kim
J Korean Med Sci.2007;22(3):557-559.   Published online 2007 June 30     DOI: http://dx.doi.org/10.3346/jkms.2007.22.3.557
      
6 A Case of Intolerance to Warfarin Dosing in an Intermediate Metabolizer of CYP2C9
Soo-Youn Lee, June Soo Kim, Jong-Won Kim
Yonsei Med J.2005;46(6):843-846.   Published online 2005 December 31     DOI: http://dx.doi.org/10.3349/ymj.2005.46.6.843
      

 1 of 1